CareStart G6PD Rapid Tests

Product Enquiry


G6PD deficiency is a genetic disorder, resulting in no or low G6PD activity. People with G6PD deficiency should not take primaquine, an antimalarial drug, and other drugs with high oxidative stress because it could cause serious side effects such as acute hemolysis.

Features & Benefits

  • True Point-Of-Care Test for G6PD with >95% Sensitivity * for WHO classification Ⅰ&Ⅱ (<10% of normal activity)
  • CareStart™ G6PD RDT is a visual screening test that identifies G6PD deficient patients using whole blood sample.


There are no reviews yet.

Be the first to review “CareStart G6PD Rapid Tests”

Your email address will not be published. Required fields are marked *